Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
16 September 2021 | Story Nonsindiso Qwabe | Photo Supplied
Dr Samantha Potgieter.

As COVID-19 vaccines continue to be a topical issue in South Africa and indeed in the world itself, the Department of Human Resources held a webinar for the UFS community on 10 September that delved deeper into the questions surrounding the vaccine. 

Dr Samantha Potgieter, infectious disease expert at the Universitas Academic Hospital and affiliated Lecturer in the Department of Internal Medicine at the University of the Free State, addressed some commonly raised concerns about the COVID-19 vaccine and how it affects us.

Dr Potgieter started off by saying that coronaviruses have been causing outbreaks among humans for millennia. While COVID-19 is relatively mild and self-limiting in 80% of patients, 20% of patients are at risk of developing severe disease.
She said before a vaccine could be introduced to a population, it had to go through rigorous testing and clinical trials. Only once safety has been confirmed, it can be released and distributed. 

“This process usually takes about ten years; this is what we are used to. But it has happened much quicker for the COVID-19 vaccine, and I think this is a fact that many people misinterpret – that the evidence might not be that robust, which is certainly not the case. COVID-19 vaccines have gone through all this rigorous testing, thousands of patients had volunteered for trial testing studies. The point is that we already had the technology, vaccination is not something new to humans. So, these preclinical trials were able to happen very quickly, and because of the large number of infections and because the focus of the entire world was on finding a cure, it was a very set process to get these trials through the adequate phases.” 

She said the COVID-19 vaccine was approved by national regulators, manufactured to exacting standards, and only thereafter distributed – as is the case for all drugs released into the market.

How does the vaccine work?

Dr Potgieter said the vaccine works by producing antibodies against the COVID-19 virus. If you are infected with the COVID-19 virus after getting vaccinated, these antibodies bind to the virus and stop it from replicating.

“When you get infected with a disease such as COVID-19, natural antibodies are produced by the immune system to fight the disease. If you get infected again, the immune system will remember how to respond, and quickly destroy the virus. A vaccine can do the same, but without the risk of disease from natural infection. Vaccines work by imitating a bacteria or virus using either mRNA in the case of the COVID-19 vaccine, or a dead or weakened version of the bacteria or virus. The vaccine raises the body’s alarm. It trains the body to recognise and fight the virus. When the body encounters the real-deal virus, it is primed and ready to fight for the body’s health.”

She said South Africa had the mRNA vaccine in the form of the Pfizer vaccine, and the adenoviral vector vaccine in the form of the Johnson & Johnson vaccine.

Why should you get the vaccine?

Dr Potgieter said vaccines are safe and effective, and the most compelling reasons for getting vaccinated are the following:

-To protect yourself from severe disease
-To protect those around you who may be at risk of severe disease
-To restore the social and economic platforms of the country, and the world at large.
She said that while the vaccine does not prevent you from getting COVID-19, it offers better protection against the development of severe disease, and vaccinated people had 50% less chance of spreading the virus.
The most common side effects of the vaccine are the following:
-Pain at the injection site
-Swollen lymph nodes
-Fever
-Fatigue
-Headache
-Myalgia (muscle pain)

“These are indications that the immune system is mounting a response. When it mounts a response, it produces antibodies,” she said.

Answers to commonly asked questions are the following:

1. Can the vaccine alter my DNA?
“No, it goes nowhere near the nucleus of the cell.”

2. What happens when you get COVID in between the first and second doses?
“Some protection is conferred after the first dose, but maximum protection is conferred two weeks after the second dose. Vaccination is still advised.” 

Dr Potgieter said patients who were between vaccinations still show better recovery results than those without.

3. What about natural immunity?
“Natural immunity might confer better protection, but it runs the risk of severe disease. Yes, immunity can be gained through natural immunity, it can be gained through vaccination, and it can certainly be gained by a combination of the two.”

4. What about long-term side effects?
“Serious side effects that cause long-term health problems following any vaccination are very rare, including the COVID-19 vaccination.”

To get the answers to more of your questions, the webinar can be accessed via the following link: https://event.webinarjam.com/go/replay/43/053q6a8vay9a0qa2

News Archive

Qwaqwa Campus launches No Student Hungry Programme
2013-05-02

 

Samkelo Duma (white shirt) flanked by some of the guests during the launch of the NSH Programme on the Qwaqwa Campus.
Photo: Thabo Kessah
02 May 2013

The Qwaqwa Campus of the University of the Free State launched the No Student Hungry (NSH) Programme on Friday 26 April 2013. The programme aims to provide needy students with a daily balanced meal to enable them to concentrate in class and ultimately obtain their degrees. The programme – initiated by Vice-Chancellor and Rector Prof Jonathan Jansen in 2011 on the Bloemfontein Campus – already feeds hundreds of students.

Rudi Buys, Dean of Student Affairs who represented the Rectorate, encouraged students in need to focus more on their desire for greatness.

“Through this programme, you will be able you to shift your focus from the hunger pangs and rather focus all your energy on the hunger to make Africa great,” said Buys. “We want you to be different from the rest of your generation that is reluctant to compete for greatness. Many of your peers prefer mediocrity and it is our wish that through this programme, you can start learning to compete with the best,” Buys impelled.

According to the Qwaqwa Campus programme co-coordinator, Selloane Phoofolo, NSH operates on a primary and a secondary level.

“The primary level offers a food bursary to the students whose academic performance is above 65 percent and not receiving any form of financial assistance. For the 2013 academic year, we had 53 students applying and 31 have qualified. They are getting a meal for R25.00 a day at the Dining Hall,” said Phoofolo.

She further explained that, “On the secondary level, we provide monthly food parcels to 19 students who did not qualify for the food bursary. These food parcels are donated by Pick n Pay and Stop Hunger Now SA. For this, beneficiaries must undertake 40 hours of community service during the year. They must also partake in student activities. Their academic progress is monitored by the Office of Social Work.”

One of the beneficiaries, a final-year BA degree student Samkelo Duma, expressed his gratitude towards the UFS for giving him an equal opportunity to those in more fortunate situations to do his best in his studies. “It is difficult to study and concentrate on an empty stomach and I must say that the NSH is very helpful. I do not just get a meal, but I get a healthy meal to keep me going throughout the tough day,” Duma said.

Also present at the launch were the patrons of the programme, Ms Grace Jansen and Dr Carin Buys. They volunteer their time and energy to raise funds for the project.

Students apply for the allowances and are selected on the basis of financial need, academic results, active participation in student life programmes and commitment to give something back to the community.

You can also invest in these students' future by contributing R10.00 each time you sms the word 'Answer' to 38722.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept